Literature DB >> 18374660

A decade of HPLC-MS/MS in the routine clinical laboratory--goals for further developments.

Michael Vogeser1, Christoph Seger.   

Abstract

During the past decade, tandem mass spectrometry hyphenated to liquid chromatography separation systems (HPLC-MS/MS) has developed to an important technology in clinical chemistry - not only for research purposes but also for routine use. At present, most important application fields are target analyses in therapeutic drug monitoring (TDM) and metabolic disorders diagnosis. The essential strengths of HPLC-MS/MS include potentially high analytical specificity, wide range of applicability to small and large molecules, capability of multi- and mega-parametric tests, and the opportunity to develop powerful assays with a high degree of flexibility within a short time frame. The technique has overcome important limitations of GC-MS and is characterized by short analytical runtimes, applicability to thermo labile, polar and large molecules, and straightforward sample preparation. However, implementation of HPLC-MS/MS assays still requires substantial expertise and know-how. At the present, its application is limited to a rather small number of clinical routine laboratories. Nonetheless, HPLC-MS/MS has the potential to be further developed to a commonly applied high-throughput technique in clinical chemistry, complementary to present standard techniques as photometry and ligand binding methods. This review intends to characterize working characteristics of present day HPLC-MS/MS instrumentations used in clinical routine laboratories. Limitations of currently available systems and applications will be critically discussed. Required instrument improvements supporting the successful spreading of HPLC-MS/MS in laboratory medicine within the next decade will be outlined.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18374660     DOI: 10.1016/j.clinbiochem.2008.02.017

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  21 in total

1.  National Estimates of Serum Total 25-Hydroxyvitamin D and Metabolite Concentrations Measured by Liquid Chromatography-Tandem Mass Spectrometry in the US Population during 2007-2010.

Authors:  Rosemary L Schleicher; Maya R Sternberg; Anne C Looker; Elizabeth A Yetley; David A Lacher; Christopher T Sempos; Christine L Taylor; Ramon A Durazo-Arvizu; Khin L Maw; Madhulika Chaudhary-Webb; Clifford L Johnson; Christine M Pfeiffer
Journal:  J Nutr       Date:  2016-04-06       Impact factor: 4.798

Review 2.  Usage and limitations of liquid chromatography-tandem mass spectrometry (LC-MS/MS) in clinical routine laboratories.

Authors:  Christoph Seger
Journal:  Wien Med Wochenschr       Date:  2012-11-06

Review 3.  Unbiased approaches to biomarker discovery in neurodegenerative diseases.

Authors:  Alice S Chen-Plotkin
Journal:  Neuron       Date:  2014-11-05       Impact factor: 17.173

Review 4.  Ethics of drug research in the pediatric intensive care unit.

Authors:  Niina Kleiber; Krista Tromp; Miriam G Mooij; Suzanne van de Vathorst; Dick Tibboel; Saskia N de Wildt
Journal:  Paediatr Drugs       Date:  2015-02       Impact factor: 3.022

5.  Collision energy-breakdown curves - An additional tool to characterize MS/MS methods.

Authors:  Sophie Mörlein; Carina Schuster; Michael Paal; Michael Vogeser
Journal:  Clin Mass Spectrom       Date:  2020-10-20

Review 6.  DNA N6-Methyladenine Modification in Eukaryotic Genome.

Authors:  Hao Li; Ning Zhang; Yuechen Wang; Siyuan Xia; Yating Zhu; Chen Xing; Xuefeng Tian; Yinan Du
Journal:  Front Genet       Date:  2022-06-24       Impact factor: 4.772

7.  A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples.

Authors:  Christoph Seger; Karin Tentschert; Wolfgang Stöggl; Andrea Griesmacher; Steven L Ramsay
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

8.  Advances in biochemical screening for phaeochromocytoma using biogenic amines.

Authors:  Malcolm J Whiting; Matthew P Doogue
Journal:  Clin Biochem Rev       Date:  2009-02

9.  How close is the bench to the bedside? Metabolic profiling in cancer research.

Authors:  Que N Van; Timothy D Veenstra
Journal:  Genome Med       Date:  2009-01-20       Impact factor: 11.117

10.  Proper Controls to Electrochemically Evaluate Carotenoids using β-Cyclodextrin Modified Surfaces.

Authors:  Garrett Thompson; Sabrina Marnoto; Jeffrey M Halpern
Journal:  ECS Trans       Date:  2017-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.